Protagonist Therapeutics (PTGX) Reports Q4 Loss of $0.15

March 7, 2018 4:05 PM

Protagonist Therapeutics (NASDAQ: PTGX) reported Q4 EPS of ($0.15), versus ($0.67) reported last year.

For earnings history and earnings-related data on Protagonist Therapeutics (PTGX) click here.

Categories

Earnings Guidance

Next Articles